Articles Referencing CPTS
DexCom Stays at Neutral - Analyst Blog
5/23/2013, 2:28 pm from Zacks.com in Investing, Business, Stocks
On May 22, 2013, we reiterated DexCom, Inc. (
DXCM ) at Neutral
based on its first quarter 2013 earnings results. On May 1, DexCom announced results for the reported quarter. The
company... Read >>
Promising Data on Edwards' Sapien XT - Analyst Blog
5/23/2013, 2:25 pm from Zacks.com in Investing, Business, Stocks
World's leading provider of heart valves and hemodynamic
monitoring Edwards Lifesciences Corporation ( EW ) disclosed positive
one-year data on Edwards Sapien XT transcatheter aortic heart... Read >>
Covidien's ENB Adopted by ACCP - Analyst Blog
5/23/2013, 11:30 am from Zacks.com in Investing, Business, Stocks
Covidien plc ( COV ) revealed that the
American College of Chest Physicians (ACCP) has included the
company's superDimension Electromagnetic Navigation Bronchoscopy
(ENB) system in its... Read >>
BSX Entangled in Patent Issues - Analyst Blog
5/22/2013, 3:28 pm from Zacks.com in Investing, Business, Stocks
Medical technology major Boston Scientific
Corporation ( BSX ) was hit by
another patent tiff when Germany-based OrbusNeich Medical Inc. and
its subsidiary, OrbusNeich Medical GmbH enforced... Read >>
Wright Medical Stays Neutral - Analyst Blog
5/22/2013, 2:27 pm from Zacks.com in Investing, Business, Stocks
On May 21, 2013, we reiterated our Neutral recommendation for
Wright Medical Group Inc. ( WMGI ) based on its
first quarter 2013 earnings results and retention of sales guidance
for 2013. ... Read >>
Medtronic Beats Earnings, Results Stronger - Analyst Blog
5/22/2013, 10:31 am from Zacks.com in Investing, Business, Earnings, Stocks
Medtronic Inc. ( MDT ) reported
fourth-quarter fiscal 2013 earnings per share (EPS) of 95 cents, up
1% year over year. After taking into account certain one-time
items, adjusted EPS was... Read >>
THOR Downgraded to Underperform - Analyst Blog
5/21/2013, 3:28 pm from Zacks.com in Investing, Business, Stocks
On May 20, 2013, we downgraded Thoratec Corp. (
THOR ) to
Underperform based on its first quarter 2013 earnings results. On May 2, Thoratec announced its results for the reported
quarter.... Read >>
Yet Another Acquisition for Bayer - Analyst Blog
5/21/2013, 10:29 am from Zacks.com in Investing, Business, Stocks
Bayer ( BAYRY ) recently
inked a deal to acquire all shares of Germany-based Steigerwald
Arzneimittelwerk GmbH. Steigerwald Arzneimittelwerk is a private
pharmaceutical company which... Read >>
FDA Nod for COV's Advanced Nellcor - Analyst Blog
5/21/2013, 10:29 am from Zacks.com in Investing, Business, Stocks
International health care products major, Covidien
plc ( COV )
has won the approval of the U.S. Food and Drug Administration
("FDA") for its motion-tolerant Nellcor pulse oximetry... Read >>
FDA Nod for Thoratec Controller - Analyst Blog
5/20/2013, 3:03 pm from Zacks.com in Investing, Business, Stocks
Thoratec Corp. ( THOR ), a leader in
mechanical circulation support devices, recently revealed that it
has received approval from the Food and Drug Administration (FDA)
to sell the... Read >>
PKI Downgraded to Underperform - Analyst Blog
5/20/2013, 2:02 pm from Zacks.com in Investing, Business, Stocks
On May 16, 2013, we downgraded our recommendation on
PerkinElmer Inc. ( PKI ) to Underperform
based on its first quarter earnings results and reduced
guidance. On Apr 25, PerkinElmer... Read >>
CE Mark for STJ's ILUMIEN OPTIS - Analyst Blog
5/17/2013, 2:29 pm from Zacks.com in Investing, Business, Stocks
Medical devices major, St. Jude Medical Inc. (
STJ ) has won CE
Mark approval for its ILUMIEN OPTIS Percutaneous Coronary
Intervention (PCI) Optimization System. This intravascular... Read >>
Stryker Reiterated at Neutral - Analyst Blog
5/17/2013, 1:30 pm from Zacks.com in Investing, Business, Stocks
On May 16, we retained Stryker Corp. ( SYK ) at Neutral,
following its first-quarter results. Stryker's reported solid sales
in the U.S. but international markets, especially Europe,... Read >>
Alleged Patent Infringement by BSX - Analyst Blog
5/17/2013, 12:30 pm from Zacks.com in Investing, Business, Stocks
After a series of positive news, medical technology major
Boston Scientific Corporation ( BSX ) received a patent
infringement complaint from Vascular Solutions
Inc. ( VASC ), a... Read >>
Covidien Prices Senior Notes - Analyst Blog
5/16/2013, 9:29 am from Zacks.com in Investing, Business, Stocks
Healthcare major, Covidien plc ( COV ) announced that
its fully-owned subsidiary Covidien International Finance S.A.
(CIFSA) will be offering 2.950% underwritten senior notes due 2023
for... Read >>